1,833
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Recurrence and Survival Rates of Patients Who Undergo Minimally Invasive Surgery for Endometrial Carcinoma with Different Prognostic Risk Groups

, , , , &
Pages 1-10 | Received 12 Jun 2022, Accepted 11 Sep 2022, Published online: 07 Nov 2022

References

  • Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660.
  • Aimagambetova G, Terzic S, Lagana AS, Bapayeva G, la Fleur P, Terzic M. Contemporary fertility-sparing management options of early stage endometrioid endometrial cancer in young nulliparous patients. JCM. 2021;11(1):196. doi:10.3390/jcm11010196.
  • Terzic M, Aimagambetova G, Kunz J, et al. Molecular Basis of endometriosis and endometrial cancer: Current knowledge and future perspectives. IJMS. 2021;22(17):9274. doi:10.3390/ijms22179274.
  • Concin N, Creutzberg CL, Vergote L, et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer. 2021;31(1):12–39. doi:10.1136/ijgc-2020-002230.
  • Abu-Rustum NR, Yashar CM, Bradley K, et al. NCCN Guidelines(R) Insights: Uterine Neoplasms, Version 3.2021. J Natl Compr Canc Netw. 2021;19(8):888–895. doi:10.6004/jnccn.2021.0038.
  • Janda M, Gebski V, Davies LC, et al. Effect of total laparoscopic hysterectomy vs total abdominal hysterectomy on disease-free survival among women with stage i endometrial cancer: A randomized clinical trial. JAMA. 2017;317(12):1224–1233. doi:10.1001/jama.2017.2068.
  • Walker JL, Piedmonte MR, Spirtos NM, et al. Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study. J Clin Oncol. 2012;30(7):695–700. doi:10.1200/JCO.2011.38.8645.
  • Ramirez PT, Frumovitz M, Pareja R, et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer. N Engl J Med. 2018;379(20):1895–1904. doi:10.1056/NEJMoa1806395.
  • Galaal K, Donkers H, Bryant A, Lopes AD. Laparoscopy versus laparotomy for the management of early stage endometrial cancer. Cochrane Database Syst Rev. 2018;10:CD006655. doi:10.1002/14651858.CD006655.pub3.
  • Nasioudis D, Frey MK, Chapman-Davis E, Caputo TA, Holcomb K. Outcomes of minimally invasive surgery for patients with endometrial carcinoma involving the cervix. Int J Gynecol Cancer. 2020;30(5):619–625. doi:10.1136/ijgc-2019-001023.
  • Miguel L, Silva JCR, Poli Neto OB, et al. A propensity score-matched case-control study of laparoscopy and laparotomy for endometrial cancer. Rev Assoc Med Bras. 2021;67(5):753–758. doi:10.1590/1806-9282.20210194.
  • Kotani Y, Murakami K, Fujishima R, et al. Research article quality of life after laparoscopic hysterectomy versus abdominal hysterectomy. BMC Womens Health. 2021;21(1):219. doi:10.1186/s12905-021-01364-8.
  • Mourits MJ, Bijen CB, Arts HJ, et al. Safety of laparoscopy versus laparotomy in early-stage endometrial cancer: a randomised trial. Lancet Oncol. 2010;11(8):763–771. doi:10.1016/S1470-2045(10)70143-1.
  • Nasioudis D, Heyward QD, Haggerty AF, et al. Surgical and oncologic outcomes of minimally invasive surgery for stage I high-grade endometrial cancer. Surg Oncol. 2020;34:7–12. doi:10.1016/j.suronc.2020.02.015.
  • Tanaka T, Ueda S, Miyamoto S, et al. Oncologic outcomes for patients with endometrial cancer who received minimally invasive surgery: a retrospective observational study. Int J Clin Oncol. 2020;25(11):1985–1994. doi:10.1007/s10147-020-01744-4.
  • Kim SI, Park DC, Lee SJ, et al. Survival rates of patients who undergo minimally invasive surgery for endometrial cancer with cervical involvement. Int J Med Sci. 2021;18(10):2204–2208. doi:10.7150/ijms.55026.
  • Sasada S, Yunokawa M, Takehara Y, et al. Baseline risk of recurrence in stage I-II endometrial carcinoma. J Gynecol Oncol. 2018;29(1):e9. doi:10.3802/jgo.2018.29.e9.
  • Chiva L, Zanagnolo V, Querleu D, et al. SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer. Int J Gynecol Cancer. 2020;30(9):1269–1277. doi:10.1136/ijgc-2020-001506.
  • Kanao H, Matsuo K, Aoki Y, et al. Feasibility and outcome of total laparoscopic radical hysterectomy with no-look no-touch technique for FIGO IB1 cervical cancer. J Gynecol Oncol. 2019;30(3):e71. doi:10.3802/jgo.2019.30.e71.
  • Barnes EA, Martell K, Parra-Herran C, Taggar AS, Donovan E, Leung E. Substantial lymphovascular space invasion predicts worse outcomes in early-stage endometrioid endometrial cancer. Brachytherapy. 2021;20(3):527–535. doi:10.1016/j.brachy.2020.12.006.
  • Jaishankar S, Pifer PM, Bhargava R, et al. Is substantial lymphovascular space invasion prognostic for clinical outcomes in type II endometrial cancer? Clin Oncol (R Coll Radiol). 2022;34(7):452–458. doi:10.1016/j.clon.2022.02.018.
  • Dou Y, Song K, Fu Y, et al. Risk factors and prognosis of early recurrence in stage I-II endometrial cancer: A large-scale, multi-center, and retrospective study. Front Med (Lausanne). 2022;9:808037. doi:10.3389/fmed.2022.808037.
  • Padilla-Iserte P, Lago V, Tauste C, et al. Impact of uterine manipulator on oncological outcome in endometrial cancer surgery. Am J Obstet Gynecol. 2021;224(1):65 e1–65 e11. doi:10.1016/j.ajog.2020.07.025.
  • Chen S, Zheng Y, Tong L, Zhao X, Chen L, Wang Y. Laparoendoscopic single-site radical hysterectomy with vaginal closure and without uterine manipulator for FIGO IB1 cervical cancer. J Minim Invasive Gynecol. 2020;27(7):1471–1472. doi:10.1016/j.jmig.2020.01.003.
  • Ding B, Guan X, Duan K, Shen Y. Laparoscopic radical hysterectomy with enclosed colpotomy without the use of uterine manipulator for early-stage cervical cancer. J Minim Access Surg. 2021;17(4):570–572. doi:10.4103/jmas.JMAS_146_20.
  • Volz J, Köster S, Spacek Z, Paweletz N. The influence of pneumoperitoneum used in laparoscopic surgery on an intraabdominal tumor growth. Cancer. 1999;86(5):770–774. doi:10.1002/(sici)1097-0142(19990901)86:5 < 770::aid-cncr11 > 3.0.co;2-3.
  • Gunusen I, Akdemir A, Gurel C, et al. The effects of different pressure pneumoperitoneum models created by standard or heated-humidified CO2 insufflation on ovary and peritoneum: an experimental study in rats. Reprod Sci. 2022;29(4):1197–1208. doi:10.1007/s43032-022-00878-2.
  • Stolnicu S, Terinte C, Ioanid N, Silva E. Presence of tumor cells in the vagina during surgical treatment could be the source of vaginal recurrence in patients with endometrial carcinoma - A pilot prospective study. Ann Diagn Pathol. 2020;46:151503. doi:10.1016/j.anndiagpath.2020.151503.
  • Nasioudis D, Sakamuri S, Ko EM, et al. Radical hysterectomy is not associated with a survival benefit for patients with stage II endometrial carcinoma. Gynecol Oncol. 2020;157(2):335–339. doi:10.1016/j.ygyno.2020.02.003.
  • Talhouk A, McConechy MK, Leung S, et al. A clinically applicable molecular-based classification for endometrial cancers. Br J Cancer. 2015;113(2):299–310. doi:10.1038/bjc.2015.190.
  • Leon-Castillo A, Horeweg N, Peters EEM, et al. Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment. Gynecol Oncol. 2022;164(3):577–586. doi:10.1016/j.ygyno.2022.01.007.
  • Cosgrove CM, Tritchler DL, Cohn DE, et al. An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer. Gynecol Oncol. 2018;148(1):174–180. doi:10.1016/j.ygyno.2017.10.037.
  • Kandoth, C, Schultz, N, Cherniack, AD, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497(7447):67–73. doi:10.1038/nature12113.